(Q28212636)
Statements
Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans (English)
0 references
4 August 2004
0 references
44
0 references
3
0 references
635-41
0 references